Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term refers to a class of orthopedic implants—such as the Catamaran SI Joint Fusion System, iFuse Implant System, TriCor, CornerLoc—used to mechanically stabilize the sacroiliac joint in patients with sacroiliac joint dysfunction or instability[1][3][5][7]. These devices are typically made from medical-grade titanium and are designed to "transfix" (cross/anchor) the joint, promoting osseointegration and bony fusion. They often consist of hollow or fenestrated implants that allow graft bone packing to stimulate fusion across the SI joint. Placement is done via minimally invasive surgical approaches, using imaging guidance to optimize positioning and minimize risk to surrounding structures. The device's role is entirely mechanical—it is not a pharmacologic or molecular target but a hardware solution for joint stabilization and pain reduction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sacroiliac joint stabilization via integrated transfixing titanium anchor.